Director/PDMR Shareholding

RNS Number : 4214R
Plant Health Care PLC
01 March 2023
 

 

 

Plant Health Care plc

 

("Plant Health Care" or "the Company")

 

Director Dealings / PDMR Shareholding


Plant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, has been informed that on 27 February 2023, Dr Christopher Richards, Chairman of the Company, transferred 1,487,958 ordinary shares of 0.01 pence each in the capital of the Company ("Ordinary Shares") held by him to an ISA held in the name of him and his wife. This transfer was effected by the sale of 1,487,958 Ordinary Shares at a price of £0.10402 pence per Ordinary Share and the immediate repurchase of 1,487,958 Ordinary Shares at a price of £0.104 per Ordinary Share.  

 

Following this transfer, the total number of Ordinary Shares held by Dr Richards and persons closely associated with him is unchanged and those parties are beneficially interested in 4,285,527 Ordinary Shares, representing approximately 1.4% of the Company's issued share capital.

 

 

Enquiries

 

 

Plant Health Care plc

+1 919 926 1600

Jeff Tweedy - CEO




Cenkos Securities plc - Nomad & Broker

Neil McDonald / Peter Lynch

+44 (0) 131 220 9771

Company website: www.planthealthcare.com

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Christopher Richards

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

b)

LEI

 

213800KBQPJZ2FM8QH27

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary Shares of 1p each


GB00B
01JC540

b)

Nature of the transaction

1.  Sale of Shares

2.  Sale of Shares

3.  Purchase of Ordinary Shares

4.  Purchase of Ordinary Shares

c)

Price(s) and volume(s)


Price(s)

Volume(s)

1. 

£0.10402

542,000

2. 

£0.10402

945,958

3. 

£0.104

542,000

4. 

£0.104

945,958




d)

Aggregated information

-

Aggregated volume

-

 

Price

 

Sale of Ordinary Shares: 1,487,958

Purchase of Ordinary Shares: 1,487,958


Sale of Ordinary Shares: £0.10402

Purchase of Ordinary Shares: £0.104

e)

Date of the transaction

27.02. 202 3

f)

Place of the transaction

AIM, London Stock Exchange

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEDEEAEDSEFE
UK 100

Latest directors dealings